Ernexa Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Ernexa Therapeutics Inc. has filed 1,520 SEC EDGAR filings since 14 Feb 1994

SEC filing history

Showing 176-200 of 1,000 matching filings.

Per page
25
Current page
8
SC 13D/A File 005-42217

AMENDMENT NO. 1 TO SCHEDULE 13D

Filing date
26 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-487908

D filing

Filing date
26 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-487907

D filing

Filing date
26 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-42217

SC 13G/A

Filing date
21 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jul 2023
Reporting date
14 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jul 2023
Reporting date
14 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Jul 2023
Reporting date
14 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
11 Jul 2023
Reporting date
06 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
11 Jul 2023
Reporting date
06 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 Jun 2023
Reporting date
21 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-11460

DEFA14A

Filing date
10 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-11460

ARS

Filing date
05 May 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-11460

DEFA14A

Filing date
05 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-11460

DEF 14A

Filing date
05 May 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-271279

424B3

Filing date
25 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-271279

EFFECT filing

Filing date
24 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
20 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-11460

PRE 14A

Filing date
20 Apr 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .